STOCK TITAN

Director Wang (STAA) discloses 3,257,130 indirect STAAR Surgical shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

STAAR Surgical director Christopher Min Fang Wang filed an initial ownership report showing indirect beneficial ownership of 3,257,130 shares of common stock. The holdings consist of 2,575,061 shares owned by Yunqi Path Capital Master Fund and 682,069 shares owned by Yunqi China Special Investment A. Through his roles with the Yunqi entities, Mr. Wang may be deemed to beneficially own these shares, but he disclaims beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wang Christopher Min Fang

(Last) (First) (Middle)
UNIT 3703, 37/F AIA TOWER
183 ELECTRIC ROAD, NORTH POINT

(Street)
HONG KONG K3 00000

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/14/2026
3. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share 3,257,130 I See footnote(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Consists of (i) 2,575,061 shares of Common Stock, par value $0.01 per share ("Common Stock") beneficially owned by Yunqi Path Capital Master Fund, a Cayman Islands domiciled fund ("Yunqi Master Fund") and (ii) 682,069 shares of Common Stock beneficially owned by Yunqi China Special Investment A, a company incorporated in the Cayman Islands ("Yunqi A"). As the sole owner of Yunqi Capital Cayman Limited, a company incorporated in the Cayman Islands, the controller of Yunqi Master Fund, and as the Chief Investment Officer of Yunqi Capital Limited, the investment advisor of Yunqi Master Fund and Yunqi A, Mr. Wang may be deemed to beneficially own the 3,257,130 shares of Common Stock beneficially owned in the aggregate by Yunqi Master Fund and Yunqi A. Mr. Wang disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
/s/ Christopher Min Fang Wang 02/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider position does Christopher Min Fang Wang hold at STAAR Surgical (STAA)?

Christopher Min Fang Wang is reported as a director of STAAR Surgical. The filing indicates he is not listed as an officer or 10% owner, and the Form 3 is filed as an initial statement of his beneficial ownership relationship with the company.

How many STAAR Surgical (STAA) shares are reported as beneficially owned?

The Form 3 reports 3,257,130 shares of STAAR Surgical common stock as indirectly beneficially owned. This total combines shares held by Yunqi Path Capital Master Fund and Yunqi China Special Investment A, which are investment entities associated with Christopher Min Fang Wang.

Which entities actually hold the STAAR Surgical (STAA) shares reported on the Form 3?

The filing states that 2,575,061 shares are beneficially owned by Yunqi Path Capital Master Fund and 682,069 shares by Yunqi China Special Investment A. Both entities are Cayman Islands vehicles connected to investment firms associated with Christopher Min Fang Wang.

Does Christopher Min Fang Wang directly own STAAR Surgical (STAA) shares?

The Form 3 shows all 3,257,130 shares as held indirectly, referencing a footnote. It explains that Wang may be deemed to beneficially own shares through Yunqi entities but disclaims beneficial ownership except for his pecuniary interest in those holdings.

What type of security is reported in this STAAR Surgical (STAA) Form 3 filing?

The filing covers common stock with a par value of $0.01 per share. It reports indirect beneficial ownership of these common shares, with no derivative securities listed in the derivative securities table for this initial ownership statement.

Is this STAAR Surgical (STAA) Form 3 reporting a transaction or just current holdings?

This Form 3 reflects current beneficial holdings rather than a new trade. The transaction section shows a holding entry tied to 3,257,130 shares indirectly owned following the reported event date, with no specific purchase or sale price disclosed.
Staar Surg

NASDAQ:STAA

STAA Rankings

STAA Latest News

STAA Latest SEC Filings

STAA Stock Data

859.46M
49.48M
0.56%
111.03%
8.06%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MONROVIA